553 related articles for article (PubMed ID: 22332764)
1. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
Burgess BA; Tokateloff N; Manning S; Lohmann K; Lunn DP; Hussey SB; Morley PS
J Vet Intern Med; 2012; 26(2):384-92. PubMed ID: 22332764
[TBL] [Abstract][Full Text] [Related]
2. Neuropathogenic and non-neuropathogenic variants of equine herpesvirus 1 in France.
Pronost S; Léon A; Legrand L; Fortier C; Miszczak F; Freymuth F; Fortier G
Vet Microbiol; 2010 Oct; 145(3-4):329-33. PubMed ID: 20427133
[TBL] [Abstract][Full Text] [Related]
3. Equine herpesvirus-1 myeloencephalopathy: a review of recent developments.
Pusterla N; David Wilson W; Madigan JE; Ferraro GL
Vet J; 2009 Jun; 180(3):279-89. PubMed ID: 18805030
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR.
Ataseven VS; Dağalp SB; Güzel M; Başaran Z; Tan MT; Geraghty B
Res Vet Sci; 2009 Apr; 86(2):339-44. PubMed ID: 18649902
[TBL] [Abstract][Full Text] [Related]
5. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
[TBL] [Abstract][Full Text] [Related]
6. Case-control study of a multistate equine herpesvirus myeloencephalopathy outbreak.
Traub-Dargatz JL; Pelzel-McCluskey AM; Creekmore LH; Geiser-Novotny S; Kasari TR; Wiedenheft AM; Bush EJ; Bjork KE
J Vet Intern Med; 2013; 27(2):339-46. PubMed ID: 23398291
[TBL] [Abstract][Full Text] [Related]
7. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses.
Giessler KS; Goehring LS; Jacob SI; Davis A; Esser MM; Lee Y; Zarski LM; Weber PSD; Hussey GS
J Gen Virol; 2024 May; 105(5):. PubMed ID: 38767608
[TBL] [Abstract][Full Text] [Related]
8. Virological and serological investigation of Equid herpesvirus 1 infection in New Zealand.
Dunowska M; Gopakumar G; Perrott MR; Kendall AT; Waropastrakul S; Hartley CA; Carslake HB
Vet Microbiol; 2015 Apr; 176(3-4):219-28. PubMed ID: 25666453
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of equine herpesvirus myeloencephalopathy in France: a clinical and molecular investigation.
Pronost S; Legrand L; Pitel PH; Wegge B; Lissens J; Freymuth F; Richard E; Fortier G
Transbound Emerg Dis; 2012 Jun; 59(3):256-63. PubMed ID: 21975071
[TBL] [Abstract][Full Text] [Related]
10. Equine Herpesvirus-1 Myeloencephalopathy, an Emerging Threat of Working Equids in Ethiopia.
Negussie H; Gizaw D; Tessema TS; Nauwynck HJ
Transbound Emerg Dis; 2017 Apr; 64(2):389-397. PubMed ID: 26010868
[TBL] [Abstract][Full Text] [Related]
11. Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 and IgG4/7 mucosal antibodies.
Eady NA; Holmes C; Schnabel C; Babasyan S; Wagner B
J Virol; 2024 Jun; 98(6):e0025024. PubMed ID: 38742875
[TBL] [Abstract][Full Text] [Related]
12. Prevention of equine herpesvirus myeloencephalopathy - Is heparin a novel option? A case report.
Walter J; Seeh C; Fey K; Bleul U; Osterrieder N
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2016 Oct; 44(5):313-317. PubMed ID: 27652372
[TBL] [Abstract][Full Text] [Related]
13. Detection of equine herpesvirus-1 in nasal swabs of horses by quantitative real-time PCR.
Perkins GA; Goodman LB; Dubovi EJ; Kim SG; Osterrieder N
J Vet Intern Med; 2008; 22(5):1234-8. PubMed ID: 18691363
[TBL] [Abstract][Full Text] [Related]
14. Equine herpesvirus 1 myeloencephalopathy.
Pusterla N; Hussey GS
Vet Clin North Am Equine Pract; 2014 Dec; 30(3):489-506. PubMed ID: 25300635
[TBL] [Abstract][Full Text] [Related]
15. Viremia and nasal shedding for the diagnosis of equine herpesvirus-1 infection in domesticated horses.
Pusterla N; Dorman DC; Burgess BA; Goehring L; Gross M; Osterrieder K; Soboll Hussey G; Lunn DP
J Vet Intern Med; 2024; 38(3):1765-1791. PubMed ID: 38069548
[TBL] [Abstract][Full Text] [Related]
16. Detection and management of an outbreak of equine herpesvirus type 1 infection and associated neurological disease in a veterinary teaching hospital.
Goehring LS; Landolt GA; Morley PS
J Vet Intern Med; 2010; 24(5):1176-83. PubMed ID: 20584137
[TBL] [Abstract][Full Text] [Related]
17. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
[TBL] [Abstract][Full Text] [Related]
18. Prevalence factors associated with equine herpesvirus type 1 infection in equids with upper respiratory tract infection and/or acute onset of neurological signs from 2008 to 2014.
Pusterla N; Mapes S; Akana N; Barnett C; MacKenzie C; Gaughan E; Craig B; Chappell D; Vaala W
Vet Rec; 2016 Jan; 178(3):70. PubMed ID: 26607427
[TBL] [Abstract][Full Text] [Related]
19. Neurological disease associated with EHV-1-infection in a riding school: clinical and virological characteristics.
van Maanen C; Sloet van Oldruitenborgh-Oosterbaan MM; Damen EA; Derksen AG
Equine Vet J; 2001 Mar; 33(2):191-6. PubMed ID: 11266070
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
